PFE logo

Pfizer (PFE) Cash from financing

annual CFF:

-$17.14B-$43.21B(-165.76%)
December 31, 2024

Summary

  • As of today (May 29, 2025), PFE annual cash flow from financing activities is -$17.14 billion, with the most recent change of -$43.21 billion (-165.76%) on December 31, 2024.
  • During the last 3 years, PFE annual CFF has fallen by -$7.32 billion (-74.61%).
  • PFE annual CFF is now -165.76% below its all-time high of $26.07 billion, reached on December 31, 2023.

Performance

PFE Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

quarterly CFF:

-$5.23B-$113.00M(-2.21%)
March 29, 2025

Summary

  • As of today (May 29, 2025), PFE quarterly cash flow from financing activities is -$5.23 billion, with the most recent change of -$113.00 million (-2.21%) on March 29, 2025.
  • Over the past year, PFE quarterly CFF has dropped by -$296.00 million (-6.00%).
  • PFE quarterly CFF is now -119.24% below its all-time high of $27.17 billion, reached on June 1, 2023.

Performance

PFE quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

TTM CFF:

-$17.44B-$296.00M(-1.73%)
March 29, 2025

Summary

  • As of today (May 29, 2025), PFE TTM cash flow from financing activities is -$17.44 billion, with the most recent change of -$296.00 million (-1.73%) on March 29, 2025.
  • Over the past year, PFE TTM CFF has dropped by -$41.34 billion (-172.94%).
  • PFE TTM CFF is now -166.89% below its all-time high of $26.07 billion, reached on December 31, 2023.

Performance

PFE TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

PFE Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-165.8%-6.0%-172.9%
3 y3 years-74.6%+20.5%-28.3%
5 y5 years-102.0%-137.6%-686.1%

PFE Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-165.8%at low-119.2%+20.5%-166.9%at low
5 y5-year-165.8%at low-119.2%+62.1%-166.9%+20.6%
alltimeall time-165.8%+25.8%-119.2%+62.1%-166.9%+24.5%

PFE Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$5.23B(+2.2%)
-$17.44B(+1.7%)
Dec 2024
-$17.14B(-165.8%)
-$5.11B(+10.3%)
-$17.14B(+160.3%)
Sep 2024
-
-$4.64B(+88.5%)
-$6.58B(+15.0%)
Jun 2024
-
-$2.46B(-50.1%)
-$5.73B(-124.0%)
Mar 2024
-
-$4.93B(-190.6%)
$23.91B(-8.3%)
Dec 2023
$26.07B(-275.7%)
$5.44B(-244.0%)
$26.07B(+67.0%)
Sep 2023
-
-$3.78B(-113.9%)
$15.61B(+14.5%)
Jun 2023
-
$27.17B(-1080.7%)
$13.63B(-223.6%)
Mar 2023
-
-$2.77B(-44.7%)
-$11.03B(-25.7%)
Dec 2022
-$14.83B(+51.1%)
-$5.01B(-12.9%)
-$14.83B(+12.6%)
Sep 2022
-
-$5.76B(-328.6%)
-$13.17B(+54.8%)
Jun 2022
-
$2.52B(-138.3%)
-$8.51B(-37.4%)
Mar 2022
-
-$6.58B(+96.3%)
-$13.59B(+38.4%)
Dec 2021
-$9.82B(+1.7%)
-$3.35B(+204.4%)
-$9.82B(-51.5%)
Sep 2021
-
-$1.10B(-56.9%)
-$20.25B(-7.8%)
Jun 2021
-
-$2.56B(-8.9%)
-$21.97B(+114.2%)
Mar 2021
-
-$2.81B(-79.6%)
-$10.26B(+6.3%)
Dec 2020
-$9.65B(+13.7%)
-$13.79B(+388.7%)
-$9.65B(-668.3%)
Sep 2020
-
-$2.82B(-130.8%)
$1.70B(-78.2%)
Jun 2020
-
$9.16B(-516.3%)
$7.79B(-451.3%)
Mar 2020
-
-$2.20B(-9.8%)
-$2.22B(-73.9%)
Dec 2019
-$8.48B(-58.5%)
-$2.44B(-174.5%)
-$8.48B(-31.9%)
Sep 2019
-
$3.27B(-484.6%)
-$12.45B(-27.3%)
Jun 2019
-
-$851.00M(-89.9%)
-$17.13B(-5.8%)
Mar 2019
-
-$8.47B(+32.2%)
-$18.19B(-11.0%)
Dec 2018
-$20.44B(+53.1%)
-$6.41B(+355.7%)
-$20.44B(+15.0%)
Sep 2018
-
-$1.41B(-26.3%)
-$17.78B(-1.7%)
Jun 2018
-
-$1.91B(-82.2%)
-$18.08B(-5.6%)
Mar 2018
-
-$10.72B(+186.4%)
-$19.16B(+43.5%)
Dec 2017
-$13.35B(+44.7%)
-$3.74B(+118.8%)
-$13.35B(+12.0%)
Sep 2017
-
-$1.71B(-42.8%)
-$11.92B(+0.4%)
Jun 2017
-
-$2.99B(-39.1%)
-$11.87B(+70.5%)
Mar 2017
-
-$4.91B(+112.1%)
-$6.96B(-24.5%)
Dec 2016
-$9.23B(-11.3%)
-$2.31B(+39.2%)
-$9.23B(+12.4%)
Sep 2016
-
-$1.66B(-186.7%)
-$8.21B(+20.5%)
Jun 2016
-
$1.92B(-126.7%)
-$6.81B(-35.8%)
Mar 2016
-
-$7.17B(+454.2%)
-$10.60B(+1.9%)
Dec 2015
-$10.41B(+2.2%)
-$1.29B(+392.0%)
-$10.41B(-15.0%)
Sep 2015
-
-$263.00M(-86.0%)
-$12.24B(-17.7%)
Jun 2015
-
-$1.87B(-73.1%)
-$14.87B(-1.1%)
Mar 2015
-
-$6.98B(+123.2%)
-$15.03B(+47.6%)
Dec 2014
-$10.19B(-32.0%)
-$3.13B(+8.3%)
-$10.19B(-20.4%)
Sep 2014
-
-$2.89B(+41.5%)
-$12.80B(-17.6%)
Jun 2014
-
-$2.04B(-4.4%)
-$15.55B(-11.4%)
Mar 2014
-
-$2.13B(-62.9%)
-$17.54B(+17.1%)
Dec 2013
-$14.97B(-6.4%)
-$5.74B(+2.0%)
-$14.97B(-3.2%)
Sep 2013
-
-$5.63B(+39.6%)
-$15.46B(+17.8%)
Jun 2013
-
-$4.03B(-1029.5%)
-$13.12B(+8.8%)
Mar 2013
-
$434.00M(-107.0%)
-$12.06B(-24.6%)
Dec 2012
-$16.00B(-22.4%)
-$6.23B(+89.4%)
-$16.00B(-0.1%)
Sep 2012
-
-$3.29B(+10.9%)
-$16.02B(-4.4%)
Jun 2012
-
-$2.97B(-15.4%)
-$16.76B(-5.4%)
Mar 2012
-
-$3.51B(-43.9%)
-$17.71B(-14.1%)
Dec 2011
-$20.61B(+84.4%)
-$6.25B(+54.9%)
-$20.61B(+33.5%)
Sep 2011
-
-$4.04B(+3.0%)
-$15.44B(+10.9%)
Jun 2011
-
-$3.92B(-38.8%)
-$13.92B(-3.1%)
Mar 2011
-
-$6.40B(+493.5%)
-$14.37B(+28.6%)
Dec 2010
-$11.17B(-177.2%)
-$1.08B(-57.2%)
-$11.17B(-12.9%)
Sep 2010
-
-$2.52B(-42.1%)
-$12.83B(+5.7%)
Jun 2010
-
-$4.36B(+35.8%)
-$12.13B(-842.1%)
Mar 2010
-
-$3.21B(+17.4%)
$1.64B(-88.7%)
Dec 2009
$14.48B(-320.7%)
-$2.73B(+49.6%)
$14.48B(-3.2%)
Sep 2009
-
-$1.83B(-119.4%)
$14.96B(+3.8%)
Jun 2009
-
$9.41B(-2.4%)
$14.41B(+547.1%)
Mar 2009
-
$9.63B(-527.7%)
$2.23B(-133.9%)
Dec 2008
-$6.56B(-48.0%)
-$2.25B(-5.3%)
-$6.56B(+45.6%)
Sep 2008
-
-$2.38B(-14.4%)
-$4.51B(-29.4%)
Jun 2008
-
-$2.78B(-427.5%)
-$6.38B(-7.7%)
Mar 2008
-
$848.00M(-524.0%)
-$6.91B(-45.2%)
Dec 2007
-$12.61B
-$200.00M(-95.3%)
-$12.61B(-24.3%)
Sep 2007
-
-$4.25B(+28.5%)
-$16.66B(-4.9%)
DateAnnualQuarterlyTTM
Jun 2007
-
-$3.31B(-31.7%)
-$17.52B(-8.7%)
Mar 2007
-
-$4.85B(+14.0%)
-$19.18B(-17.0%)
Dec 2006
-$23.10B(+150.5%)
-$4.25B(-16.6%)
-$23.10B(+59.1%)
Sep 2006
-
-$5.10B(+2.5%)
-$14.52B(+28.7%)
Jun 2006
-
-$4.98B(-43.2%)
-$11.28B(-34.3%)
Mar 2006
-
-$8.77B(-302.6%)
-$17.17B(+86.2%)
Dec 2005
-$9.22B(+39.1%)
$4.33B(-332.3%)
-$9.22B(-45.4%)
Sep 2005
-
-$1.86B(-82.9%)
-$16.90B(-11.2%)
Jun 2005
-
-$10.87B(+1228.6%)
-$19.03B(+110.8%)
Mar 2005
-
-$818.00M(-75.6%)
-$9.03B(+36.2%)
Dec 2004
-$6.63B(-60.8%)
-$3.35B(-16.2%)
-$6.63B(-23.5%)
Sep 2004
-
-$4.00B(+360.9%)
-$8.66B(+5.3%)
Jun 2004
-
-$867.00M(-154.8%)
-$8.22B(-45.4%)
Mar 2004
-
$1.58B(-129.4%)
-$15.07B(-10.9%)
Dec 2003
-$16.91B(+238.2%)
-$5.38B(+51.4%)
-$16.91B(+16.1%)
Sep 2003
-
-$3.56B(-53.9%)
-$14.57B(+21.9%)
Jun 2003
-
-$7.72B(+2961.9%)
-$11.95B(+137.3%)
Mar 2003
-
-$252.00M(-91.7%)
-$5.04B(+0.7%)
Dec 2002
-$5.00B(+138.5%)
-$3.04B(+223.7%)
-$5.00B(+54.4%)
Sep 2002
-
-$940.00M(+17.4%)
-$3.24B(+13.7%)
Jun 2002
-
-$801.00M(+272.6%)
-$2.85B(+55.0%)
Mar 2002
-
-$215.00M(-83.2%)
-$1.84B(-12.4%)
Dec 2001
-$2.10B(-43.4%)
-$1.28B(+133.5%)
-$2.10B(-36.8%)
Sep 2001
-
-$549.00M(-362.7%)
-$3.31B(-0.9%)
Jun 2001
-
$209.00M(-144.1%)
-$3.34B(-20.6%)
Mar 2001
-
-$474.00M(-81.0%)
-$4.21B(+13.7%)
Dec 2000
-$3.71B(+127.7%)
-$2.50B(+332.7%)
-$3.71B(+41.9%)
Sep 2000
-
-$578.00M(-12.2%)
-$2.61B(-10.8%)
Jun 2000
-
-$658.00M(-2156.3%)
-$2.93B(+23.7%)
Mar 2000
-
$32.00M(-102.3%)
-$2.37B(+45.4%)
Dec 1999
-$1.63B(-55.3%)
-$1.41B(+57.6%)
-$1.63B(-45.7%)
Sep 1999
-
-$893.00M(+811.2%)
-$3.00B(+9.7%)
Jun 1999
-
-$98.00M(-112.7%)
-$2.73B(-1.7%)
Mar 1999
-
$771.00M(-127.7%)
-$2.78B(-23.6%)
Dec 1998
-$3.64B(+342.4%)
-$2.78B(+341.8%)
-$3.64B(+162.9%)
Sep 1998
-
-$629.00M(+336.8%)
-$1.39B(+3.1%)
Jun 1998
-
-$144.00M(+61.8%)
-$1.34B(+25.4%)
Mar 1998
-
-$89.00M(-83.0%)
-$1.07B(+30.1%)
Dec 1997
-$823.00M(+124.3%)
-$523.00M(-10.9%)
-$823.00M(-30.0%)
Sep 1997
-
-$587.00M(-558.6%)
-$1.18B(+678.1%)
Jun 1997
-
$128.00M(-19.5%)
-$151.00M(+7.9%)
Mar 1997
-
$159.00M(-118.2%)
-$140.00M(-61.9%)
Dec 1996
-$367.00M(-29.3%)
-$875.00M(-300.2%)
-$367.00M(+192.2%)
Sep 1996
-
$437.00M(+214.4%)
-$125.60M(-84.7%)
Jun 1996
-
$139.00M(-304.4%)
-$821.40M(-32.2%)
Mar 1996
-
-$68.00M(-89.3%)
-$1.21B(+133.2%)
Dec 1995
-$519.10M(-938.6%)
-$633.60M(+144.8%)
-$519.10M(-238.4%)
Sep 1995
-
-$258.80M(+3.4%)
$375.00M(-21.9%)
Jun 1995
-
-$250.40M(-140.1%)
$480.10M(-38.0%)
Mar 1995
-
$623.70M(+139.4%)
$773.80M(+1150.1%)
Dec 1994
$61.90M(-104.0%)
$260.50M(-269.5%)
$61.90M(-104.3%)
Sep 1994
-
-$153.70M(-455.0%)
-$1.45B(-2.9%)
Jun 1994
-
$43.30M(-149.1%)
-$1.50B(-12.5%)
Mar 1994
-
-$88.20M(-93.0%)
-$1.71B(+9.2%)
Dec 1993
-$1.57B(+27.6%)
-$1.25B(+535.8%)
-$1.57B(+99.3%)
Sep 1993
-
-$197.30M(+15.2%)
-$786.20M(+42.4%)
Jun 1993
-
-$171.20M(-406.3%)
-$552.20M(-23.6%)
Mar 1993
-
$55.90M(-111.8%)
-$723.10M(-41.1%)
Dec 1992
-$1.23B(+367.6%)
-$473.60M(-1390.5%)
-$1.23B(+99.4%)
Sep 1992
-
$36.70M(-110.7%)
-$616.00M(-9.2%)
Jun 1992
-
-$342.10M(-23.8%)
-$678.40M(+145.8%)
Mar 1992
-
-$449.00M(-424.4%)
-$276.00M(+5.1%)
Dec 1991
-$262.60M(-47.5%)
$138.40M(-638.5%)
-$262.60M(-2.8%)
Sep 1991
-
-$25.70M(-142.6%)
-$270.30M(+26.7%)
Jun 1991
-
$60.30M(-113.8%)
-$213.30M(-25.4%)
Mar 1991
-
-$435.60M(-433.3%)
-$285.90M(-42.8%)
Dec 1990
-$499.90M(-460.2%)
$130.70M(+317.6%)
-$499.90M(-20.7%)
Sep 1990
-
$31.30M(-354.5%)
-$630.60M(-4.7%)
Jun 1990
-
-$12.30M(-98.1%)
-$661.90M(+1.9%)
Mar 1990
-
-$649.60M
-$649.60M
Dec 1989
$138.80M
-
-

FAQ

  • What is Pfizer annual cash flow from financing activities?
  • What is the all time high annual CFF for Pfizer?
  • What is Pfizer annual CFF year-on-year change?
  • What is Pfizer quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Pfizer?
  • What is Pfizer quarterly CFF year-on-year change?
  • What is Pfizer TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Pfizer?
  • What is Pfizer TTM CFF year-on-year change?

What is Pfizer annual cash flow from financing activities?

The current annual CFF of PFE is -$17.14B

What is the all time high annual CFF for Pfizer?

Pfizer all-time high annual cash flow from financing activities is $26.07B

What is Pfizer annual CFF year-on-year change?

Over the past year, PFE annual cash flow from financing activities has changed by -$43.21B (-165.76%)

What is Pfizer quarterly cash flow from financing activities?

The current quarterly CFF of PFE is -$5.23B

What is the all time high quarterly CFF for Pfizer?

Pfizer all-time high quarterly cash flow from financing activities is $27.17B

What is Pfizer quarterly CFF year-on-year change?

Over the past year, PFE quarterly cash flow from financing activities has changed by -$296.00M (-6.00%)

What is Pfizer TTM cash flow from financing activities?

The current TTM CFF of PFE is -$17.44B

What is the all time high TTM CFF for Pfizer?

Pfizer all-time high TTM cash flow from financing activities is $26.07B

What is Pfizer TTM CFF year-on-year change?

Over the past year, PFE TTM cash flow from financing activities has changed by -$41.34B (-172.94%)
On this page